IGHE and Increased total eosinophil count: Pre-clinical models of airway allergy and asthma have shown that CpG was able to reduce Th2 immunity, airway inflammation, eosinophilia, and IgE levels in both prophylactic and therapeutic settings15, 16, 17, 18, 19, 20.